ERBB2 and neoplasm: We found that HER2 CAR‐T cells acquired enhanced activation after encountering tumor antigens, as indicated by the greater upregulation of TIM‐3 and LAG‐3 (Figure 4b), along with a superior expansion potential compared to SIA‐CIgG CAR‐T cells (Figure 4c).